Renal Artery Imaging 128
and Physiologic Testing
JOSHUA W. BERNHEIM, MD
K. CRAIG KENT, MD
regarding surgical or endovascular treatments are based in
part on the arteriographic appearance of the lesion. An
Renal artery stenosis (RAS) is the most common cause of understanding of angiographic techniques for evaluation of
secondary hypertension; its prevalence in patients with the renal arteries is crucial.
hypertension is estimated to range from 1% to 5%.1-5 In
patients with associated atherosclerosis in other vascular
beds, the prevalence may be signiﬁcantly higher.6 Harding
and associates7 studied the renal arteries in 1235 patients at Arteriography can be performed with ﬁlm-screen or digital
the time of coronary angiography and found a 30% inci- subtraction techniques. In ﬁlm-screen arteriography, mul-
dence of renal artery disease. In most cases, atherosclerosis tiple sequential x-ray images are recorded on 14 × 14 inch
or ﬁbromuscular dysplasia is the cause. There has been ﬁlm during the intra-arterial injection of contrast material.
increased focus on the diagnosis and treatment of renovas- The images are reviewed after the ﬁlm is developed. This
cular disease because this form of hypertension is poten- approach is rarely used now. With digital subtraction angi-
tially curable. Control of hypertension has been associated ography (DSA), multiple sequential ﬂuoroscopic images
with a reduction in patient morbidity and mortality. acquired by an image intensiﬁer are electronically converted
Owing to the advent of multiple new antihypertensive to digital form and stored. An image obtained before con-
agents and the aging of the population, patients with athero- trast injection, the mask, is electronically subtracted from
sclerotic renal artery stenosis (RAS) are presenting later in images containing contrast material. Only the contrast
the course of their disease and with more advanced renal material is visualized. The images are displayed imme-
dysfunction. This trend has increased the association of diately on a 1024 × 1024 matrix screen for review. The DSA
ischemic nephropathy and RAS. It is estimated from an- images can be modiﬁed via the computer and stored on
giographic studies that ischemic nephropathy may be a con- computer disk or printed.
tributing factor in 43% of patients referred for dialysis or DSA is sensitive to motion artifact because it involves
renal transplantation.8-13 the subtraction of one image from another. Any movement
It has become crucial to identify accurate methods for between images degrades image quality. Patient cooperation
diagnosing RAS. Although contrast angiography remains is necessary, and carefully titrated conscious sedation is
the “gold standard,” because of its invasiveness and often helpful. For patients with large amounts of bowel gas,
attendant risks, it is not an appropriate screening test for the intravenous administration of glucagon (0.5 to 1 mg)
all patients thought to have renovascular hypertension or before image acquisition also improves evaluation of the
ischemic nephropathy. Consequently, many noninvasive abdominal aorta and its branches by decreasing peristalsis.
modalities have been developed that can be used to evaluate Small amounts of movement usually can be compensated
this disease process. The noninvasive tests can be divided for by manually shifting the subtracted mask image relative
into tests that rely on an evaluation of the physiologic to the contrast-enhanced images.
sequelae of renovascular disease (e.g., captopril test, Evaluation of the renal arteries usually begins with an
captopril scintigraphy, renal vein renins) and tests that aortic injection of contrast material. A 5F multiple side-hole
directly image the renal artery (duplex ultrasonography, catheter is placed into the aorta through a femoral or
magnetic resonance angiography [MRA], and sequential brachial artery approach14 using a modiﬁed Seldinger
helical computed tomography [spiral CT]). This chapter technique.15 Contrast material is injected with an automatic
reviews and discusses the current knowledge of available power injector while sequential images are recorded. The
renal artery imaging modalities and physiologic testing. rate and volume of contrast injection and the rate of image
acquisition are determined and speciﬁc for each patient.
In general, a contrast injection of 10 to 20 mL/sec for 2
■ ARTERIOGRAPHY seconds is usually adequate. Images usually are acquired
Despite technologic advances in noninvasive methods for at a rate of three per second for 3 to 5 seconds, followed
evaluating the renal arteries, deﬁnitive diagnosis of renal by a rate of one to two images per second for the next
artery pathology continues to depend on visualization of 5 seconds. These images allow assessment of the arterial,
renal artery anatomy with angiographic techniques. After a the nephrographic, and occasionally the venous phases
diagnosis of renal vascular disease is established, decisions of ﬂow.
1774 Section XIX THE MANAGEMENT OF RENOVASCULAR DISORDERS
For optimal visualization of the renal arteries, attention involves a phosphorus-based image intensiﬁer, which
to several technical details is required. Multiple catheters detects x-ray beams and creates an analog image, which
have been designed to optimize opaciﬁcation of the renal is converted into digital information for display and
arteries during an injection into the aorta.16,17 The catheter manipulation. Newer systems use a solid-state system that
should be positioned with the side holes at the level of detects x-rays and creates a digital image directly; this
the renal arteries, usually between the ﬁrst and second allows higher resolution with lower radiation dosages and
lumbar vertebrae. Ideally the catheter should be posi- simpliﬁed and more accurate postacquisition image
tioned low enough to avoid ﬁlling of the superior mesen- processing. Three-dimensional DSA is another revolu-
teric artery and its branches, which may overlap and tionary technique in which the tube makes a single rotation
obscure the renal arteries. The number of renal arteries around the area of interest before contrast administration,
is highly variable; multiple arteries supplying a single resulting in the acquisition of a mask. A second revolution is
kidney are seen in 20% to 30% of patients.18-20 The right performed that coincides with an injection of intra-arterial
renal artery usually arises cephalad to the left. The right renal contrast material. The mask is subtracted from the contrast
artery usually arises from the anterolateral surface of image, and three-dimensional reconstructions are created.
the aorta, whereas the left arises from the posterolateral This technique combines the three-dimensional capabili-
surface.18,21,22 When imaged from an anteroposterior projec- ties of MRA and CT angiography with the higher resolu-
tion, the proximal renal arteries can be obscured by overlap tion of DSA. A turn of the tube can take 4 seconds, and two
with the contrast-ﬁlled aorta. revolutions are required to obtain an image, so motion
Because of variability in the number and origins of the artifact is a potential problem. In addition, the arteries to
renal arteries, many studies have attempted to establish the be imaged need to be opaciﬁed for an entire 4-second
optimal rotational projection for acquiring images.23-27 Most revolution, necessitating injection of larger volumes of
often, images are acquired in anteroposterior and shallow contrast material. The beneﬁt of these new technologies is
left anterior oblique projections. Verschuyl and coworkers23 expected to become more evident as they are introduced into
performed a detailed analysis of the angles at which the clinical practice over the next few years.
renal arteries originate from the aorta using axial images
from CT scans. They found that a 15- to 20-degree left
anterior oblique projection most frequently showed the Complications of Arteriography
origins of the renal arteries without overlap of the contrast- The risks of aortography and selective renal arteriography
ﬁlled aorta. The next most useful projections were antero- can be substantial and may include complications related to
posterior, followed by a 40-degree left anterior oblique the arterial puncture (e.g., hematoma, pseudoaneurysm),
view.24 A projection error of 10 degrees was sufﬁcient to contrast-induced nephropathy, and cholesterol embolization.
obscure a signiﬁcant length of the renal artery. As non- These risks are more prevalent when arteriography is
invasive imaging modalities have gained popularity to performed in patients with advanced atherosclerosis, severe
screen for disease of the renal arteries, cross-sectional hypertension, or renal insufﬁciency,35 all frequent comor-
imaging is increasingly available before arteriography. bidities with RAS. The prevalence of these complications in
Careful evaluation of noninvasive images often allows a this speciﬁc patient group is not well understood because
prediction of the precise projection that would best depict large published studies of conventional angiography
the renal arteries. This approach can save unnecessary generally include “uncomplicated patients” who have only
injections of contrast material in patients who are already at renovascular hypertension and normal renal function. The
high risk for contrast nephropathy. complications of angiography are often insidious and difﬁcult
Aortography with optimized technique usually provides to assess accurately, especially retrospectively. Among 2374
adequate evaluation of the main renal arteries and the patients who underwent contrast angiography as part of the
segmental and subsegmental branches.28-31 In some cases, Cooperative Study of Renovascular Hypertension,36 a
selective catheterization of the renal arteries32 allows better fatality rate of 0.11%, a nonfatal major complication rate of
visualization of the oriﬁce and distal branches without 1.2%, and a minor complication rate of 2.7% were observed.
overlap from the aorta or other vessels. Catheterization of The authors of this study relied on self-reporting by
the renal artery usually is performed with a preshaped radiologists at many different centers. The subjects were
Cobra, Omni Selective, or Simmons (all three manufactured principally patients who had normal renal function.
by Angio Dynamics, Queensbury, NY) type of catheter, with Contrast nephropathy is discussed in detail in Chapter 58.
hand injection of contrast material or power injection of The incidence of contrast-induced nephropathy varies signi-
3 to 6 mL of contrast material per second for 1 to 2 seconds. ﬁcantly and has been reported to range from 0 to 7%, with
Selective renal arteriography limits the total volume of the largest studies reporting an average incidence of 3%.37
contrast material used for imaging in renal vessels in Risk factors for the development of acute contrast-induced
multiple obliquities. Selective arteriography also provides nephrotoxicity include dehydration,38renal insufﬁciency,39-43
the opportunity to evaluate the hemodynamic effects of a and diabetes mellitus.41,43,44 In some studies, the combination
stenosis. This evaluation can be accomplished with direct of diabetes and renal insufﬁciency has been shown to increase
pressure measurements proximal and distal to the lesion.33,34 the risk to 20% to 50% depending on the degree of pre-
The ability to measure pressures across a RAS is valuable existing renal dysfunction.45 Diabetic patients with renal
and is not available with noninvasive imaging modalities. insufﬁciency are at highest risk. In patients who do not have
Numerous new technologies currently are being inves- risk factors, acute contrast-induced nephrotoxicity is usually
tigated and warrant mention. Traditional image acquisition transient.41,42,46-49
C H A P T E R 128 Renal Artery Imaging and Physiologic Testing 1775
Atheroembolism is an increasingly recognized com- have validated the efﬁcacy of N-acetyl cysteine.64-67 The
plication of renal arteriography. It tends to be under- mechanism of N-acetyl cysteine’s protective effect is poorly
diagnosed because it is an insidious disorder that is difﬁcult understood but may be related to increased nitric oxide
to identify with certainty without performing a biopsy.50 production and decreased oxidative stress.68 Although
Only the most fulminant cases are recognized clinically. conﬂicting studies in the literature show no beneﬁt,69-72 the
Although clinical studies generally have reported a low benign nature and low cost of this agent have led to its
incidence (1.4% in one large series51), autopsy studies found widespread and liberal application.
evidence of atheroemboli in 25% to 30% of patients who Despite the failure of dopamine infusion to prevent
died within 6 months after cardiac catheterization or contrast-induced nephropathy,73,74 Bakris and colleagues75
aortography.52 Patients with widespread atherosclerotic showed in a dog model that fenoldopam mesylate, a selec-
disease and preexisting renal insufﬁciency—precisely the tive dopamine-1 receptor antagonist, prevented the decrease
population at risk for ischemic nephropathy—are the in glomerular ﬁltration rate (GFR) and renal blood ﬂow
patients who are most susceptible to atheroembolism. associated with intravenous contrast injection. In 2001,
Although conventional angiography can detect the Hunter and coworkers76 reported a series of 29 patients
anatomic presence of a renal artery lesion, it does not pro- with diabetes and renal insufﬁciency who received fenold-
vide data on the physiologic or hemodynamic signiﬁcance. opam before angiography. Only one patient experienced an
Also, because conventional angiography provides only a increase in creatinine. Tumlin and colleagues,77 in a
two-dimensional image and does not allow imaging of randomized trial, showed a signiﬁcant beneﬁt to fenoldopam
the renal artery in multiple planes, it can be difﬁcult to infusion. Other studies, including a randomized, controlled
determine the precise degree of stenosis. Even when trial involving 315 patients with baseline renal insufﬁciency
multiple views are obtained, it can be difﬁcult to identify (CONTRAST investigators),78 have failed to show beneﬁt,
accurately the origin of a tortuous renal artery that arises however. Because use of fenoldopam is more involved and
from a severely diseased aorta. Despite these limitations, if costlier than N-acetyl cysteine, it has not gained popularity.
the index of suspicion for RAS is high and the patient has Larger randomized, multicenter trials are needed to conﬁrm
reasonably acceptable renal function, it may be appropriate its beneﬁt.
in certain circumstances to proceed directly to conventional For patients at signiﬁcant risk for contrast-induced
angiography without performing a noninvasive study. nephrotoxicity or who have an allergy to iodinated contrast
material, exposure can be drastically limited or entirely
Contrast Material avoided if carbon dioxide (CO2) is used as the contrast
agent. Intravascular CO2 was ﬁrst used for the diagnosis of
Intravascular administration of contrast material has been pericardial effusions in the 1950s.79 Extensive animal testing
established as a risk factor for the development of renal established its intravascular use to be safe, even with the
insufﬁciency.53,54 Factors that appear to increase the risk of administration of massive volumes.80,81 CO2 passes rapidly
renal dysfunction include use of high volumes of contrast through the capillary bed and is absorbed or routed through
material55-59 and use of high-osmolar contrast.60 Iodixanol, the venous system back to the heart and eliminated through
an isosmolar contrast agent available since the late 1990s, the lungs.82 Repeated, large-volume CO2 injections made at
may provide reduced risk.61 There also may be an advantage frequent intervals can produce a “vapor lock,” which rarely
to non-ionic contrast material. In a prospective, randomized, can cause transient ischemia. In addition, injection of CO2
double-blinded, multicenter trial involving 1196 patients into the intracranial circulation has never been proved
undergoing cardiac angiography, Rudnick and colleagues39 safe in humans, and its use in animals has resulted in
found that the use of a non-ionic contrast agent did not unexplained complications.83 It also is crucial to prevent
inﬂuence the incidence of renal failure in the study popu- room air from entering the injection system to avoid an air
lation as a whole. In patients with the highest risk (i.e., embolus. Several technical factors become important when
patients with renal insufﬁciency with or without diabetes), using CO2. Ideally a dedicated CO2 injector should be
the use of non-ionic contrast was beneﬁcial. Patients with used, but some authors have been successful in creating
renal insufﬁciency receiving diatrizoate (ionic) were 3.3 “homemade” systems, using great care to avoid contami-
times more likely to develop acute nephrotoxicity compared nation with air and overinjection.84 Ample time between
with patients receiving iohexol (non-ionic). injections should be allowed for clearance of the bolus—
Several measures to prevent acute contrast-induced usually 2 to 3 minutes to prevent vapor lock. Volumes of 25
nephrotoxicity have been evaluated, including pretreat- to 80 mL over 1 second are usually adequate to image the
ment with mannitol, diuretics, calcium channel blockers, abdominal aorta. An attempt should be made to keep total
theophylline, or dopamine (see Chapter 58). No signiﬁcant volumes less than 400 mL. Elevation of the kidney of
beneﬁt of any of these agents over simple infusion of saline interest facilitates ﬁlling of the vessel owing to the buoyancy
has been shown yet.62 Two agents that have received a great of the gas. Movement of bowel gas, a bigger problem than
deal of attention are N-acetyl cysteine and fenoldopam. In a with standard angiography, can be minimized by the
landmark study in 2000, Tepel and coworkers63 evaluated administration of an antiperistaltic agent.
N-acetyl cysteine in a randomized, prospective, placebo- It is widely believed that gas entry into the mesenteric
controlled study comprising 83 patients with chronic renal circulation causes the abdominal bloating, pressure, and
insufﬁciency. Two percent of patients in the treatment arm cramps that patients sometimes experience during injec-
developed a signiﬁcant increase in serum creatinine versus tions. End-hole catheters may produce a smoother bolus
21% of the control patients. Several subsequent studies than ﬂush catheters when using CO2 because they do not
1776 Section XIX THE MANAGEMENT OF RENOVASCULAR DISORDERS
break up the “bubble.” Stacking of consecutive images is imaging modalities realize that, under some circumstances
often helpful because of the rapid transit of the gaseous (particularly because of the three-dimensional capabilities
contrast in the arterial system. CO2 results in images with of many of these techniques), these studies may be more
lower resolution than with contrast angiography; however, revealing and accurate than contrast angiography. The
with experience CO2 can be used effectively for renal artery ultimate test of any imaging technique designed to screen
imaging.85-93 If necessary, supplemental views with a limited for RAS is its capability of identifying which patients would
volume of low-osmolar iodinated contrast material can be respond clinically to renal artery revascularization.
acquired after the optimal projection has been determined It is difﬁcult to obtain consensus on the diagnostic
with CO2.85,88,94,95 In this manner, optimal high-quality accuracy and utility of the various noninvasive methods
images of the renal arteries can be obtained with 2 to 10 mL of renal artery imaging. For each modality, investigators
of contrast material. Angiograms of diagnostic quality are have employed a variety of approaches and techniques.
obtained in 79% to 95% of patients, with sensitivity and Compounding this problem is the fact that the parameters of
speciﬁcity of 83% and 99%.96,97 reporting often vary from one institution to another. In many
Another potential alternate contrast material is gado- studies, the threshold for determining signiﬁcant RAS is
pentetate dimeglumine (gadolinium), which is the contrast 50%. Most clinicians reserve intervention for renal artery
agent routinely used during magnetic resonance imaging lesions that are greater than 70%, however. Finally, patients
(MRI). Gadopentetate dimeglumine does not pose a risk of entered into these studies are almost exclusively patients
nephrotoxicity,98-100 but it costs approximately four times who have been referred for angiography. This “selected”
more than low-osmolar iodinated contrast material. Adverse population tends to have a high prevalence of renal artery
reactions have been reported and include nausea, headache, disease. It is difﬁcult to extrapolate from the results of these
and dizziness in 3% of patients and signs of asymptomatic studies to a patient cohort that is being screened, because
hemolysis in 1% to 3%.101,102 These side effects are minor, disease is much less prevalent in the latter group.
however, and often self-limited. Also, hypocalcemia has
been observed in patients who have received large quantities
of gadolinium. It is recommended that doses not exceed Duplex Ultrasonography
0.25 mmol/kg because larger doses have not been proved Duplex ultrasonography is the imaging modality that has
safe.103-105 Ailawadi and colleagues101 reported adequate been most intensively investigated. Duplex ultrasonography
visualization in 38 renal arteries that were evaluated only combines direct visualization of the renal artery via B-mode
with gadolinium. There were no adverse effects on renal imaging with Doppler measurement of the velocity of blood
function in any of the patients studied. The major obstacles ﬂow. This combination affords anatomic evaluation and
to the widespread adoption of gadolinium-based agents in hemodynamic assessment of the renal vessels.106 Duplex
renal artery imaging are lower contrast resolution and the ultrasonography also allows simultaneous measurement of
high cost of these agents. In high-risk patients, gadolinium kidney size. Resistive indices of the segmental arteries can
remains an effective alternative to iodinated contrast be measured by duplex scanning; these values also may be
material. useful in predicting response to renal revascularization.
■ NONINVASIVE RENAL
Because of the depth of the renal arteries and their location
ARTERY IMAGING in the retroperitoneum, it is difﬁcult with B-mode imaging
An ideal noninvasive imaging study would serve as an to assess directly the luminal anatomy along the entire
accurate screening tool for RAS and a means for delineat- length of the renal artery and its branches. Instead, ultra-
ing renal anatomy before arterial reconstruction. Other sound is used to locate the main renal artery. After the renal
attributes of the ideal imaging technique are minimal artery is identiﬁed, Doppler measurements can be sampled
expense, excellent accuracy, good reproducibility, and low sequentially at regular intervals along its length and in
complication rate. In recent years, numerous, less invasive the kidney itself. These measurements are processed into
renal artery imaging strategies have been evaluated. Each spectral velocity waveforms using fast Fourier transform
has its advantages and disadvantages, but overall these analysis (Fig. 128-1). A signiﬁcant stenosis is indicated by
studies are safer than conventional angiography. As opposed an increase in velocity, which reﬂects acceleration of the
to the traditional screening tests that rely on physiologic blood as it crosses the area of narrowing. Alternatively, with
criteria (i.e., captopril test, radionuclide renography, renal indirect techniques, a proximal stenosis can be inferred from
vein renins), noninvasive imaging studies require no an abnormal Doppler waveform in the more distal segmental
preprocedural adjustments in a patient’s medication or diet. arteries of the kidney.
Also, their accuracy is not diminished by renal insufﬁciency. The main renal artery should be examined with the
Noninvasive imaging techniques also can supply detailed patient fasting to avoid interference from overlying bowel
anatomic information that potentially might obviate the gas. A low-frequency transducer (range 2 to 3.5 Hz) should
need for preoperative angiography. be used, and Doppler-shifted signals should be obtained at
In all investigations of noninvasive imaging modalities to less than a 60-degree angle to the artery. It is essential to
date, contrast angiography has been used as the standard of survey the entire renal artery, including the proximal,
comparison. Because of the previously mentioned limita- middle, and distal portions. If the artery is not examined
tions of conventional angiography, there is no true standard. carefully throughout its length, signiﬁcant stenoses, espe-
Clinicians who have worked extensively with noninvasive cially stenoses that are the consequence of ﬁbromuscular
C H A P T E R 128 Renal Artery Imaging and Physiologic Testing 1777
FIGURE 128-1 Duplex ultrasound
spectral analysis and corresponding
angiogram for a patient with unilat-
eral renal artery stenosis. Arrows A,
B, and C indicate the approximate
sites along the renal artery where the
Doppler measurements were obtained.
disease (which can be focal or distal or both), may be main RAS.114-119 The exact site of the renal artery lesion can
missed. The examination can be performed without discon- be accurately ascertained in 80% to 95% of patients.153
tinuing antihypertensive medications and is appropriate Other investigators have been unable to duplicate these
even for patients who have advanced renal insufﬁciency. excellent results. Sensitivities of 0 and rates of inadequate
Numerous parameters have been reported for the iden- examinations of 40% have been reported.120-123 There are
tiﬁcation of a hemodynamically signiﬁcant main RAS.107-111 many limitations to duplex ultrasonography that may account
The most widely accepted criteria are (1) a ratio of the peak for these variations in accuracy. Frequently encountered
systolic velocity in the renal artery to the peak systolic technical difﬁculties include inability to identify the main
velocity in the adjacent aorta greater than 3.5:1 and (2) a renal artery because of overlying fat or bowel gas, difﬁculty
peak systolic velocity in the renal artery greater than 180 interrogating the entire length of the renal artery, and
to 200 cm/sec in association with post-stenotic turbulence. inability to obtain an optimal angle of insonation. Traditional
In numerous studies, these criteria have correlated with duplex ultrasonography techniques do not allow accurate
an “angiographic stenosis” of greater than 60%. An end- identiﬁcation of accessory renal arteries,120,124 which may
diastolic velocity (EDV) 150 cm/sec or greater may signify be present in 30% of kidneys.125 This information may be
an 80% or greater angiographic stenosis.112 The absence of clinically important because stenosis of an accessory renal
a ﬂow signal in the renal artery signiﬁes an occlusion. artery is frequently the cause of reversible renovascular
Direct interrogation of the renal arteries is a labor- hypertension.
intensive and time-consuming undertaking that requires a Numerous attempts have been made to overcome these
dedicated and experienced technologist and a cooperative limitations. The most studied of these is the method of
patient. In centers where this test has been developed and indirect Doppler evaluation of the distal renal arterial tree.
studied extensively, excellent results have been obtained. In Through a ﬂank approach, segmental waveforms are
one of the earliest large studies, Hansen and coworkers113 obtained at the hilum and the upper, middle, and lower poles
evaluated 74 consecutive patients with duplex ultrasonog- of the kidney. The presence of a more proximal high-
raphy and conventional angiography. Duplex ultrasonography grade renal artery lesion is inferred when a tardus or
predicted the presence of a main RAS greater than 60% with parvus waveform is observed in the distal vessels (Fig.
a sensitivity of 93% and speciﬁcity of 98% when only 128-2). The hemodynamic signiﬁcance of these lesions is
kidneys with single renal arteries were evaluated. When determined by evaluating the acceleration time (normal
patients with multiple renal arteries also were considered, value < 0.07 second), acceleration index (normal value
the sensitivity decreased to 88%, although the speciﬁcity > 3 m/sec2), and waveform pattern recognition. Many
remained high (99%). Other centers also have reported published series have shown this technique to have excel-
sensitivities that range from 84% to 98% and speciﬁcities of lent accuracy in predicting angiographically signiﬁcant
90% to 98% for the detection of angiographically signiﬁcant RAS.126-130 Radermacher and associates126 used this tech-
1778 Section XIX THE MANAGEMENT OF RENOVASCULAR DISORDERS
FIGURE 128-2 Waveforms obtained from indirect duplex ultrasound analysis of the distal renal arterial tree. A, Graphic representation of a normal
waveform. B, Graphic representation of an abnormal waveform that would indicate the presence of signiﬁcant renal artery stenosis. C, Waveform represents
a normal study; the acceleration time (AT) was calculated to be 0.025 sec (normal < 0.07 sec), and the acceleration index (AI) was 7.51 m/sec2 (normal
>3 m/sec2). D, Waveform represents a highly abnormal study suggestive of renal artery stenosis with an AT of 0.242 sec and AI of 2.46 m/sec2.
nique as an adjunct when direct evaluation of the renal nephrosclerosis or glomerulosclerosis. It is hypothesized
artery failed or was difﬁcult. With this approach, these that these kidneys are unlikely to beneﬁt from revascu-
investigators eliminated technical failures with a resultant larization. Radermacher and associates131 reported on 131
decrease in the time required to perform the test. In other patients who underwent successful renal revasculariza-
studies using indirect Doppler techniques, a measurement tion. Patients who had a RI greater than 0.8 were highly
called the resistive index (RI) has been used as a criterion for unlikely to beneﬁt from surgery or angioplasty. Such
RAS (normal RI < 0.70). This value, which estimates the patients experienced less improvement in blood pressure
state of renal arterial resistance, is deﬁned as follows: and more frequent deterioration of renal function. In
contrast, most patients with lower RIs beneﬁted, with 94%
Peak systolic shift minimum diastolic shift experiencing a decline in blood pressure and only 3%
Peak systolic shift progressing to dialysis.131
Indirect techniques have many potential advantages over
This measurement has decreased speciﬁcity because it direct interrogation of the renal artery. Segmental waveform
also can be elevated in the presence of medical renal disease, analysis is much less time-consuming, and the results may
decreased cardiac output, or perinephric or subcapsular be less dependent on operator experience than the results
ﬂuid collections. Others have used the RI not as a tool to derived from direct renal artery interrogation. Because the
determine the presence of RAS, but as a predictor of examination is performed from a lateral approach, adequate
response to renal revascularization. The higher the RI, the data can be obtained even in obese patients and patients
more likely the kidney is affected by severe underlying who have excessive bowel gas. Accessory renal artery
C H A P T E R 128 Renal Artery Imaging and Physiologic Testing 1779
disease can be identiﬁed by a damped waveform isolated to Duplex ultrasonography also has been used intraopera-
a kidney pole.132 tively to detect and allow correction of technical problems
Disadvantages of the indirect technique include the that occasionally complicate renal artery bypass or endar-
inability to distinguish a severe stenosis from an obstruction terectomy.125,141 The superﬁcial location of the transplanted
and the lack of information regarding the exact location of a kidney also makes this study well suited for investigating
stenotic lesion. The systolic features of renal artery spectral suspected transplant RAS.142-144 Finally, duplex ultraso-
analysis are affected by increased renovascular resistance nography has been used to evaluate the results and long-
(see Fig. 128-1). Increased resistance may change distal term patency after percutaneous renal angioplasty or
renal artery acceleration time or acceleration index in stenting or both.145,146
40% of hemodynamically signiﬁcant stenoses associated One drawback of duplex ultrasonography is that it does
with renal insufﬁciency.107,113 In preliminary studies, several not provide the necessary anatomic information that
investigators have shown that the sensitivity of this would allow surgical intervention without ﬁrst obtaining a
technique can be enhanced by using an ultrasound contrast contrast angiogram. Duplex ultrasonography is accurate in
agent or by administration of captopril before the detecting celiac artery stenoses,147 however, and this
study.133-135 Many centers, including our own, have begun to information may be useful in patients with severely diseased
perform direct examination of the renal arteries and indirect aortas when hepatorenal or splenorenal bypass is being
segmental waveform analysis routinely. considered.
Renal artery duplex ultrasonography is an excellent
screening test for hemodynamically signiﬁcant RAS in
Emerging Strategies centers where the appropriate technical expertise is
Other strategies have been employed to improve the accu- available. Of the various alternatives for noninvasive
racy of main renal artery interrogation. In a few preliminary imaging, duplex ultrasonography is the least expensive.
studies, intravenous contrast agents signiﬁcantly enhanced Adding indirect techniques and using contrast agents may
the diagnostic accuracy of duplex ultrasonography. These increase its accuracy and reproducibility further, which
agents may decrease examination time and increase would make it a more widely acceptable study for RAS
accuracy by allowing (1) easier identiﬁcation of the main screening. In addition, measurement of the RI has shown
renal artery and (2) detection of a larger percentage of promise in predicting which patients will respond to
accessory renal arteries. Claudon and associates136 reported revascularization.
that intravenous administration of SH U 508A (Levovist)
before duplex examination increased the number of
technically successful studies from 64% to 84%. Contrast Magnetic Resonance Angiography
administration also seemed to increase accuracy, with 70% MRA also has been extensively evaluated as a method for
of enhanced scans correlating with angiography versus only noninvasively evaluating RAS. MRA can show vascular
52% of nonenhanced studies. Although the overall accuracy anatomy and generate an image that is similar in appearance
of duplex ultrasonography in this trial was less than what to that obtained by conventional angiography (Fig. 128-3).
has been reported in other single-institution studies, these In contrast to conventional angiography, however, MRA
results may be representative of what can be achieved does not require arterial puncture or nephrotoxic agents.
at centers without special expertise in renal duplex ultra- In contrast to the traditional physiologic studies for
sonography. At least in this setting, contrast agents seem to RAS, there is no need to discontinue antihypertensive
improve accuracy. Although ultrasound contrast agents may medications, which interfere with the renin-angiotensin
prove to be adjuncts in the evaluation of RAS by duplex system, and the accuracy of MRA does not diminish
ultrasonography, larger, more thorough studies must be because of renal dysfunction. The similarity of the images
conducted to determine their deﬁnitive role. generated by MRA and by conventional angiography
increases the comfort level of clinicians. There are
signiﬁcant differences in these images, however, and the
Other Clinical Applications interpretation of renal MRA requires speciﬁc expertise and
In addition to being a screening tool, duplex ultraso- experience.
nography has proved useful for numerous other clinical The physics of MRA is complex, and a complete descrip-
applications. Because it is noninvasive and can assess tion of this technique is beyond the scope of this chapter.
kidney size and the degree of stenosis, duplex ultraso- The clinician should have a basic understanding of the
nography has become the procedure of choice for following fundamental principles that underlie MRA, however, to
patients with documented renal artery disease who are being recognize its advantages and limitations. Numerous differ-
treated medically.137,138 Duplex ultrasonography also can ent MRA techniques can be used to image the renal
be used to monitor long-term patency after surgical recon- arteries.148,149 In early studies, two imaging techniques were
struction of the renal arteries. Studies have conﬁrmed that a employed: time of ﬂight (TOF) and phase contrast (PC).
normal postoperative duplex scan is highly predictive of a With both, protons in tissue and blood are charged when the
patent bypass graft.139,140 Because of their size and position body is exposed to a magnetic ﬁeld. The protons emit a
adjacent to the abdominal aorta, aortorenal grafts are often signal that is registered as a visual image. TOF imaging
easier to assess than native renal arteries. Hepatorenal, relies on ﬂow-related enhancement to image the renal
splenorenal, and iliorenal bypasses are more difﬁcult to arteries. With multiple magnetic pulses delivered at short
study, but a skilled technician often can successfully scan intervals, stationary protons are “saturated” so that they no
even these. longer yield signal, whereas moving protons yield maximal
1780 Section XIX THE MANAGEMENT OF RENOVASCULAR DISORDERS
FIGURE 128-3 A, Three-dimensional gadolinium-enhanced magnetic resonance angiogram shows severe left renal artery stenosis. B, The corresponding
conventional contrast angiogram from the same patient.
signal. PC imaging relies on the differences in phase shift gadolinium clearance, and detection of turbulent ﬂow
between moving and stationary protons. resulting in signal loss in nonenhanced studies all may be
More recently, a third approach called three-dimensional used to detect the physiologic sequelae of RAS.151-155 The
gadolinium-enhanced MRA has become the standard of care clinical applicability of these techniques awaits further
in renal artery MRI. With this technique, many of the investigation.
shortcomings of TOF and PC MRA have been overcome,
including (1) saturation effects that can make vessels with
relatively slow ﬂow appear stenotic; (2) turbulence-induced Clinical Experience
signal loss, which results in overestimation of stenoses; and Using a breath-holding, three-dimensional gadolinium-
(3) long imaging times. Rather than image individual enhanced method, DeCobelli and coworkers156 achieved
protons in ﬂowing blood, this method allows direct 100% sensitivity and 97% speciﬁcity for RAS greater than
visualization of the contrast agent ﬁlling the lumen similar 50%. Using these same techniques, they correctly identiﬁed
to conventional angiography. When this technique was signiﬁcantly more accessory renal arteries than could be
initially developed, long acquisition times (approximately found using a PC technique. Many other investigators also
2 to 3 minutes) were necessary; however, distal and acces- have reported excellent results with three-dimensional
sory arteries could not be assessed accurately owing to gadolinium-enhanced MRA.157-162 Hany and coworkers163
respiration artifact. More recently, rapid bolus injections reported the largest series to date, which included a
used with suspended respiration have produced slightly comparison of 103 patients who underwent gadolinium-
poorer resolution, but less pronounced respiratory artifact. enhanced MRA and contrast angiography. Using this tech-
Data from MRA are compiled initially as multiple, thin, nique, these investigators reported a sensitivity and speci-
contiguous cross-sectional slices. The slices are converted ﬁcity of 93% and 90%. Using a combination of anatomic
into a three-dimensional data set, which can be used to images from gadolinium-enhanced MRA and physiologic
create projections in any orientation that look like conven- data from cine PC MRI, Schoenberg and colleagues164 also
tional angiograms. The most commonly used reconstruction showed excellent correlation between MRI and digital
technique is called a maximal intensity projection (MIP).150 angiography in the evaluation of RAS.
In contrast to conventional angiography, MRA allows data Because of the high degree of accuracy associated with
to be projected in multiple planes (axial, coronal, sagittal, MRA and its ability to image arterial anatomy, in certain
oblique). This ﬂexibility is particularly useful for inves- cases surgeons may proceed directly to operation for RAS
tigating the renal ostium and tortuous renal arteries. To without preoperative conventional contrast angiography.165
assess the degree of stenosis accurately, it is necessary to This advantage has become less relevant as angioplasty and
examine the nonreformatted axial images because the endoluminal stents have become widely applied to RAS.
reformatting process, although it produces visually satisfy- MRA remains an important screening test for renal artery
ing images, often can lead to overestimation or underesti- disease, however. MRA also has been evaluated for
mation of the degree of stenosis. detection of RAS in transplants, although not as thoroughly
In addition to deﬁning the anatomy, attention has as has duplex ultrasonography. Although the accuracy has
focused on the use of MRA to evaluate several physi- been satisfactory when MRA is used for this purpose, false-
ologic parameters. PC ﬂow measurements, assessment of positive ﬁndings occur frequently.166-168 Another potential
C H A P T E R 128 Renal Artery Imaging and Physiologic Testing 1781
FIGURE 128-4 A, Three-dimensional gadolinium-enhanced magnetic resonance angiogram shows severe ostial accessory renal artery stenosis. B, The
conventional contrast angiogram of the same accessory renal artery reveals only a mild lesion. Pull-back pressures revealed no gradient across the ostium
of this renal artery.
advantage of MRA is its ability to obtain functional and The most striking aspect of MRA, as used to detect
anatomic data.169 Several investigators have been able to proximal renovascular disease, is its extremely low false-
estimate split renal function accurately with clearance of negative rate. In most series, sensitivity is almost 100%,
gadolinium contrast agents using a method similar to con- which makes it an excellent screening tool for suspected
ventional radionuclide renography.170-172 Others have used ischemic nephropathy secondary to atherosclerotic disease
gated MRI techniques to assess accurately renal blood ﬂow of the main renal artery. Because of this high negative
in patients with renal artery disease.173,174 It is also possible predictive value, a clinician can be conﬁdent that with a
to obtain the rates of tissue diffusion and perfusion; both of normal MRA study, functionally signiﬁcant renal artery
these measurements may help to delineate the physiologic disease is exceedingly unlikely. Because of its current
signiﬁcance of RAS.175 tendency to overestimate the degree of stenosis, MRA is
Although the popularity of MRA for noninvasive less accurate than conventional contrast angiography in
imaging is increasing, it has many limitations. False-positive deﬁning high-grade RAS; however, MRA technology is
scans are common (Fig. 128-4). MRA has a general continually evolving, and the images are expected to
tendency to overestimate the degree of stenosis. Although continue to improve.
images may appear strikingly detailed, they do not strictly
correlate with luminal anatomy. Breath-holding, three-
dimensional gadolinium-enhanced MRA is now the MRA
Helical (Spiral) Computed Tomography
technique most often used for imaging the renal vasculature. Helical CT has emerged as a promising technique for
Although it seems to afford superior resolution of accessory identifying RAS. Spiral CT employs a rotating gantry,
and branch renal arteries, few patients with ﬁbromuscular or which allows numerous images to be acquired over a
other distal renal artery lesions have been studied. MRA is relatively brief time. For arterial imaging, intravenous
not the screening test of choice for patients who may harbor iodinated contrast material is injected through a peripheral
such lesions. Three-dimensional gadolinium-enhanced MRA vein. After an appropriate delay to allow passage of the
also requires patients to hold their breath for a short time, contrast agent into the renal arterial circulation, a series of
which may be difﬁcult for patients with signiﬁcant cardiac thin cuts are obtained throughout the aorta at the level of
or pulmonary disease. Some patients are unable to tolerate the renal arteries. Rapid acquisition of data afforded by
the study because of claustrophobia. MRA also is contra- spiral CT allows multiple images to be made precisely at
indicated in patients with pacemakers, cerebral aneurysm the moment when the contrast medium passes through the
clips, or intraocular metal devices. Neighboring surgical clip renal vessels.
artifact can produce signal voids and false-positive studies. Many technical variables must be optimized if the renal
Finally, although it is not always evident when reviewing arteries are to be imaged adequately by spiral CT.176 Several
published reports, considerable expertise is required to obtain of these parameters (collimation, table speed, pitch)
high-quality images and proper interpretation. determine the interval at which cuts are acquired. These
1782 Section XIX THE MANAGEMENT OF RENOVASCULAR DISORDERS
variables are adjusted so that sections are taken at 2- to Although helical CT has been less widely studied than
3-mm intervals,177 which afford a resolution of approxi- MRA or duplex ultrasonography, numerous centers with expe-
mately 0.5 mm (whereas that for MRA is 1 to 1.5 mm). It is rience in helical CT have produced favorable results.179-183
also necessary to adjust the rate of injection and the interval Wittenberg and coworkers184 prospectively compared helical
between peripheral injection and renal artery imaging. CT and conventional angiography in 82 consecutive patients
Optimizing both of these timing variables allows maximal suspected to have renal artery disease. Helical CT detected
enhancement of the renal arteries by contrast medium. If the stenoses greater than 50% with sensitivity of 96% and
contrast bolus arrives in the renal arteries too early, the speciﬁcity of 99%. Five adrenal masses were incidentally
volume of contrast is inadequate for complete visualization detected. In 50 patients with suspected renovascular disease,
of the renal vessels. If the bolus arrives after imaging has Deregi and coworkers185 found helical CT to have sensitivity
begun, contrast returning from the renal vein might obscure of 100% and speciﬁcity of 98% for main renal artery lesions
the renal artery. The importance of precise timing has more extensive than 50%. The two false-positive results in
led many investigators to administer a test bolus using 15 this study were related to difﬁculty imaging the right main
to 20 mL of contrast material. Interval imaging over 30 renal artery adjacent to the vena cava. When accessory renal
seconds allows the physician to estimate when contrast arteries were included in this evaluation, the sensitivity
enhancement of the renal vessels is maximal. Breath holding decreased to 88%. Kim and associates186 studied 50 patients
longer than 20 seconds is required during image acquisition. with CT angiography, and conventional CT. These authors
It is essential that patients remain immobile for these studies reported a 90% sensitivity and a 97% speciﬁcity for CT
because motion artifact reduces the quality of the images. angiography in the detection of RAS greater than 50%.
The entire study takes only 20 to 30 minutes. In addition to its great accuracy, other advantages of
After the raw images are acquired, postprocessing is the helical CT include the ability to determine renal size,
next step. Initially the data are interpolated into axial cortical thickness, and, potentially, kidney perfusion.187 It
sections, then reconstructed images are rendered. This also affords simultaneous evaluation for aortic aneurysms
time-consuming process takes 30 to 90 minutes for an and adrenal gland anatomy in patients suspected to have
experienced radiologist or technician. Although many secondary hypertension.188-190 In contrast to MRA, helical
reconstructive techniques exist, the techniques currently CT can be used to assess the patency of renal arteries that
available on most commercial CT systems are MIP and have been treated with endoluminal stents.
surface-shaded display (SSD). Images provided by these The principal drawback of spiral CT for imaging renal
two techniques differ, as does the information they relay.178 arteries is the necessity for iodinated contrast medium. For
MIP is a method wherein the raw data are reconstructed most studies, 120 to 150 mL of contrast agent is required.
using the maximum-intensity signal along each ray through This is a quantity signiﬁcantly greater than that required for
the data set (Fig. 128-5A and B). MIP enhances visual digital subtraction angiography (15 to 20 mL if selective
distinction between the blood vessel and background tissue. renal images need not be obtained). For this reason, helical
The images are two-dimensional, however, and depth CT may not be appropriate for the increasing number of
relationships are not apparent, and overlapping vessels are patients with renal insufﬁciency who undergo screening for
not clearly delineated. Displaying multiple MIP images renal artery disease.
minimizes this problem. SSD has the advantage of three- Similar to duplex ultrasonography and MRA, helical CT
dimensional representation of anatomic relationship (Fig. does not produce satisfactory images of accessory renal
128-5C). Depending on the chosen threshold, however, SSD arteries.177 Although these arteries often can be identiﬁed,
can exaggerate stenoses, and surrounding structures can the extent to which they are diseased is difﬁcult to assess
produce artifacts that obscure arterial anatomy. Generally, owing to poor resolution. Because branch renal arteries tend
MIP is the more accurate of the two techniques, although to lie in a single plane, they too are often inadequately
SSD is the more visually “pleasing.” When one is deter- imaged by helical CT. Even with these limitations, CT may
mining renal artery anatomy and degree of stenosis, images be more accurate than MRA for detecting lesions related to
from all available modalities should be reviewed. In addition ﬁbromuscular disease. Other drawbacks of spiral CT include
to the MIP and SSD reconstructions, much information long postprocessing times, inability to image patients who
can be obtained by examining the original axial data or by weigh more than 125 kg, and a general tendency to produce
using multiplanar reformats. Such a complete analysis false-positive results. False-positive images can result from
allows repeated conﬁrmation of the degree of stenosis, incomplete opaciﬁcation of the renal arteries secondary to
which improves diagnostic accuracy. poor timing of a contrast bolus, overlying calciﬁcation, or
Regardless of which technique is used, the major hin- artifact from adjacent tissue. Despite these limitations, for
drance of helical CT is arterial calciﬁcation. In MIP- patients with relatively normal renal function and in
formatted images, calcium obscures the vessel lumen. centers with appropriate experience and expertise, spiral CT
Atherosclerotic disease can be inferred by the presence of offers an accurate, less invasive assessment of renal artery
calcium, but the degree of stenosis cannot be gauged anatomy.
accurately. In SSD-formatted images, it is impossible to
differentiate calcium from contrast medium. Calciﬁed
atheromas blend with intraluminal contrast and create
■ FUNCTIONAL STUDIES
the image of a widely patent vessel. Numerous calcium In 1934, Goldblatt and associates191 made the seminal dis-
suppression techniques have been studied, but they have covery that constriction of the renal artery in a dog caused
marginal utility. an elevation in blood pressure proportional to the degree of
C H A P T E R 128 Renal Artery Imaging and Physiologic Testing 1783
FIGURE 128-5 A and B, Helical computed tomography scan
postprocessed using the maximum intensity projection format in
axial (A) and coronal (B) projections reveals signiﬁcant left renal
artery stenosis. C, The same scan postprocessed using surface-
shaded display format.
constriction. Subsequent models were devised that clariﬁed found to have anatomic evidence of RAS and improve the
further the pathophysiology of different patterns of renal success of revascularization. Despite the plethora of
artery obstruction. Stenosis of a single renal artery and physiologic studies that have been evaluated and used
consequent renal hypoperfusion leads to the release of renin clinically, the perfect test remains elusive. Studies that are
and an increase in the level of angiotensin. Angiotensin currently available are evaluated here.
produces direct vasoconstriction and sodium and ﬂuid
retention. Patients with a normal functioning contralateral
kidney are able to correct for this volume expansion Renal Vein Renins
partially with a compensatory natriuresis. Intravenous pyelography and plasma vein renin levels are
A variety of noninvasive physiologic tests have been mentioned only for their historical signiﬁcance. Neither
developed and evaluated. An accurate noninvasive physiologic intravenous pyelography nor plasma vein renin level is
test could serve as a screening test for RAS. A physiologic currently used, and neither was found to predict patients
test could prove functional signiﬁcance in patients who are with RAS. Renal vein renins are still used as a method for
1784 Section XIX THE MANAGEMENT OF RENOVASCULAR DISORDERS
detecting RAS in some centers. Catheterization of the renal inhibitor renography cannot rule out RAS, however, in an
veins is an involved and invasive procedure, which is not azotemia patient or in patients with bilateral disease. Both
appropriate for screening. Renal vein renins have been subgroups are among the most important patients who
proposed as a method for determining which patients with require treatment.
RAS would respond favorably to revascularization. Patients
with renin-induced renovascular hypertension have high
renin levels in the venous drainage of the affected kidney ■ SUGGESTED PARADIGM FOR
and suppressed renin levels in the contralateral renal vein. DIAGNOSIS OF SUSPECTED
Many investigators have found a correlation between
renal vein renins and a favorable response to surgery. The RENAL ARTERY DISEASE
usefulness of this test is limited, however, because absence Renal artery disease is a complex disorder that can have
of a signiﬁcant difference in renal vein renins does not many causes and different clinical presentations. A rigid
always correlate with lack of beneﬁt of revascularization. Of diagnostic approach to suspected RAS is neither possible
patients with a negative test, 57% still have improvement nor advisable. Instead, it is more prudent to adopt a ﬂexible
after renal reconstruction.192-194 As might be anticipated, strategy that is based on each patient’s clinical presentation
patients with bilateral RAS often fail to lateralize. Selective and on “local expertise” with the various diagnostic modali-
sampling often misses accessory renal artery stenoses that ties. General recommendations for the diagnostic approach
produce renin hypersecretion in only a segment of the to patients thought to have RAS follow.
affected kidney, especially if there is separate venous When there is strong clinical suspicion of renovascular
drainage for that segment. This test is still used occasionally hypertension, and ﬁbromuscular disease is the presumed
with the caveat that a positive study is meaningful, whereas cause, it may be appropriate to proceed directly to contrast
a negative study should be placed in the context of the angiography because of the relatively high incidence of
patient’s overall clinical presentation. distal and accessory renal artery lesions. No noninvasive
imaging study currently available provides the necessary
precision in detecting these lesions.
Radionuclide Renography A traditional functional or physiologic diagnostic test can
A variety of radioisotopes can be used to determine renal be used to verify the diagnosis and predict response to
blood ﬂow and GFR. In addition, images obtained can revascularization in patients who have normal renal
be used to estimate kidney size. Interest in using nuclear function, who have suspected unilateral stenoses, and who
scintigraphy to diagnose RAS was renewed with the addi- can tolerate temporary withdrawal of certain antihyper-
tion of angiotensin-converting enzyme (ACE) inhibitors tensive medications. The number of patients thought to have
to the regimen. Protocols for the test vary among institu- RAS who have impaired renal function or who cannot
tions. Typically, after similar preparation to that used for discontinue hypertensive medications is increasing. These
non–ACE-enhanced scans, 25 to 50 mg of captopril is given patients are not optimal candidates for physiologic testing,
after a baseline scan, and repeat images are obtained and noninvasive renal artery imaging is advisable for them.
60 minutes later. In a kidney affected with RAS, the Which noninvasive modality should be used is largely a
angiotensin II–induced vasoconstriction of the efferent matter of local expertise. If there is a vascular laboratory
arteriole is acutely reduced, decreasing the GFR in that with a dedicated technician who has documented proﬁ-
kidney selectively; this is shown by a decrease in the relative ciency with renal artery duplex ultrasonography, this would
GFR in the affected kidney compared with a baseline scan. be the diagnostic modality of choice. Alternatively, if
The normal kidney responds with an increase in perfusion. there is a radiologist with experience in three-dimensional
Criteria that suggest RAS are delayed time to maximal gadolinium-enhanced MRA, MRA may be more appro-
uptake (>11 minutes) in the affected kidney, signiﬁcant priate. Experience with spiral CT is less extensive than with
asymmetry in uptake between kidneys, cortical retention of the other two modalities, but further development of this
radionuclide with captopril, and marked reduction of GFR technique is expected to make it a viable approach in
after captopril.195 selected patients with normal renal function. Although
Initial reports of this technique were quite promising. technologic advances will continue to improve the accuracy
Setaro and coauthors,196 in a study of 90 patients, showed a of noninvasive imaging for suspected RAS, sound clinical
sensitivity of 91% and a speciﬁcity of 94% in the detec- judgment is still paramount to the diagnosis and evaluation
tion of RAS greater than 50%. Several other investigators of this complicated disorder.
have reported similar results.197,198 Although a signiﬁcant
improvement over scintigraphy alone, captopril scanning is
less reliable in patients with signiﬁcant parenchymal disease ■ REFERENCES
or bilateral stenoses. In a large European trial, the positive 1. Pickering TG: Diagnosis and evaluation of renovascular hypertension:
predictive value of this test decreased from 88% to 57% in Indications for therapy. Circulation 83(Suppl I):I-147-I-154, 1991.
patients with plasma creatinine greater than 1.5 mg/dL.199 2. Mann SJ, Pickering TG: Detection of renovascular hypertension:
Currently, ACE inhibitor renography continues to play a State of the art 1992. Ann Intern Med 117:845-853, 1992.
3. Lewin A, Blaufox MD, Castle H, et al: Apparent prevalence of
role in screening of patients with suspected renovascular
curable hypertension in the hypertension detection and follow-up
hypertension. A normal captopril renogram makes the program. Arch Intern Med 145:451-455, 1985.
diagnosis of unilateral RAS highly unlikely.200 A positive 4. Berglund G, Andersson O, Wilhelmsen L: Prevalence of primary and
ﬁnding suggests a high likelihood of renovascular hyper- secondary hypertension in a random population sample. BMJ 2:554-
tension in subjects with preserved renal function. ACE 556, 1976.
C H A P T E R 128 Renal Artery Imaging and Physiologic Testing 1785
5. Bech K, Hilden T: The frequency of secondary hypertension. Acta angiography and a pigtail catheter. AJR Am J Roentgenol 169:537-
Med Scand 195:65-79, 1975. 539, 1997.
6. Olin JW, Melia M, Young JR, et al: Prevalence of atherosclerotic renal 31. Sherwood T, Ruutu M, Chisholm GD: Renal angiography problems
artery stenosis in patients with atherosclerosis elsewhere. Am J Med in live kidney donors. Br J Radiol 51:99-105, 1978.
88(1N):46N-51N, 1990. 32. Meaney TF, Dustan HP: Selective renal arteriography in the diagnosis
7. Harding MB, Smith LR, Himmelstein SI, et al: Renal artery stenosis: of renal hypertension. Circulation 28:1035-1041, 1963.
Prevalence and associated risk factors in patients undergoing routine 33. Nahman NS Jr, Maniam P, Hernandez RA Jr, et al: Renal artery
cardiac catheterization. J Am Soc Nephrol 2:1608-1616, 1992. pressure gradients in patients with angiographic evidence of athero-
8. Greco BA, Breyer JA: Atherosclerotic ischemic renal disease. sclerotic renal artery stenosis. Am J Kidney Dis 24:695-699, 1994.
Am J Kidney Dis 29:167-187, 1997. 34. Carter SA, Ritchie GW: Measurement of renal artery pressures by
9. Scoble JE, Maher ER, Hamilton G: Atherosclerotic renovascular catheterization in patients with and without renal artery stenosis.
disease causing renal impairment—a case for treatment. Clin Nephrol Circulation 33:443-449, 1966.
31:119-120, 1989. 35. Wilcox CS: Ischemic nephropathy: Noninvasive testing. Semin
10. Kahn IH, Catto GRD, Edward N: Inﬂuence of coexisting disease on Nephrol 16:43-52, 1996.
survival in renal-replacement therapy. Lancet 341:415-418, 1993. 36. Reiss MD, Bookstein JJ, Bleifer KH: Radiologic aspects of
11. Mailloux LU, Napolitano B, Bellucci AG: Renal vascular disease renovascular hypertension: Part 4. Arteriographic complications.
causing end-stage renal disease, incidence, clinical correlates, and JAMA 221:374-378, 1972.
outcomes: A 20-year clinical experience. Am J Kidney Dis 24:622- 37. Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Nephrotoxic risks of
629, 1994. renal angiography: Contrast media-associated nephrotoxicity and
12. Appel RG, Bleyer AJ, Reavis S, et al: Renovascular disease in older atheroembolism—a critical review. Am J Kidney Dis 24:713-727, 1994.
patients beginning renal replacement therapy. Kidney Int 48:171-176, 38. Eisenberg RL, Bank WO, Hedgock MW: Renal failure after major
1995. angiography can be avoided with hydration. AJR Am J Roentgenol
13. Simon P, Benarbia S, Charasse C, et al: Ischemic renal diseases have 136:859-861, 1981.
become the most frequent causes of end stage renal disease in the 39. Rudnick MR, Goldfarb S, Wesler L, et al: Nephrotoxicity of ionic and
elderly. Arch Mal Coeur Vaiss 91:1065-1068, 1998. nonionic contrast media in 1196 patients: A randomized trial. The
14. Hawkins IF Jr: “Mini-catheter” technique for femoral run-off and Iohexol Cooperative Study. Kidney Int 47:254-261, 1995.
abdominal arteriography. Am J Roentgenol Radium Ther Nucl Med 40. D’Elia JA, Gleason RE, Alday M, et al: Nephrotoxicity from
116:199-203, 1972. angiographic contrast material: A prospective study. Am J Med
15. Seldinger SI: Catheter replacement of the needle in percutaneous 72:719-725, 1982.
arteriography. Acta Radiol 39:368-376, 1953. 41. Lautin EM, Freeman NJ, Schoenfeld AH, et al: Radiocontrast-
16. Ovitt TW, Amplatz K: Semiselective renal angiography. AJR Am J associated renal dysfunction: Incidence and risk factors. AJR Am J
Roentgenol 119:767-769, 1973. Roentgenol 157:49-58, 1991.
17. Yedlicka JW Jr, Carlson JE, Hedlund LF, et al: Nonselective and 42. Moore RD, Steinberg EP, Powe NR, et al: Nephrotoxicity of high-
semiselective catheters for renal artery evaluation: Experimental osmolality versus low-osmolality contrast media: Randomized
study. J Vasc Interv Radiol 2:273-276, 1991. clinical trial. Radiology 182:649-655, 1992.
18. Bauer FW, Robbins SL: A postmortem study comparing renal angio- 43. Berns AS: Nephrotoxicity of contrast media. Kidney Int 36:730-740,
grams and renal artery casts in 58 patients. Arch Pathol 83:307-314, 1989.
1967. 44. Barrett BJ, Parfrey PS, Vavasour HM, et al: Contrast nephropathy in
19. Boijsen E: Angiographic studies of the anatomy of single and patients with impaired renal function: High versus low osmolar
multiple renal arteries. Acta Radiol 183(Suppl):23-129, 1959. media. Kidney Int 41:1274-1279, 1992.
20. Pick JW, Anson BJ: The renal vascular pedicle: An anatomical study 45. Huber W, Schipek C, Ilgmann K, et al: Effectiveness of theophylline
of 430 body halves. J Urol 44:411-434, 1940. prophylaxis of renal impairment after coronary angiography in
21. Keen EN: Origin of renal arteries from the aorta. Acta Anat (Basel) patients with chronic renal insufﬁciency. Am J Cardiol 91:1157-1162,
110:285-286, 1981. 2003.
22. Odman P, Ranninger K: The location of the renal arteries: An 46. Schwab SJ, Hlatky MA, Pieper KS, et al: Contrast nephrotoxicity: A
angiographic and postmortem study. Am J Roentgenol Radium Ther randomized controlled trial of a nonionic and an ionic radiographic
Nucl Med 104:283-286, 1968. contrast agent. N Engl J Med 320:149-153, 1989.
23. Verschuyl EJ, Kaatee R, Beek FJ, et al: Renal artery origins: Best 47. Harris KG, Smith TP, Cragg AH, Lemke JH: Nephrotoxicity from
angiographic projection angles. Radiology 205:115-120, 1997. contrast material in renal insufﬁciency: Ionic versus nonionic agents.
24. Verschuyl EJ, Kaatee R, Beek FJ, et al: Renal artery origins: Location Radiology 179:849-852, 1991.
and distribution in the transverse plane at CT. Radiology 203:71-75, 48. Parfrey PS, Grifﬁths SM, Barrett BJ, et al: Contrast material-induced
1997. renal failure in patients with diabetes mellitus, renal insufﬁciency, or
25. Gerlock AJ Jr, Goncharenko V, Sloan OM: Right posterior oblique: both: A prospective controlled study. N Engl J Med 320:143-149,
The projection of choice in aortography of hypertensive patients. 1989.
Radiology 127:45-48, 1978. 49. Taliercio CP, Vlietstra RE, Ilstrup DM, et al: A randomized
26. Harrington DP, Levin DC, Garnic JD, et al: Compound angulation for comparison of the nephrotoxicity of iopamidol and diatrizoate in high
the angiographic evaluation of renal artery stenosis. Radiology risk patients undergoing cardiac angioplasty. J Am Coll Cardiol
146:829-831, 1983. 17:384-390, 1991.
27. Garcier JM, De Fraissinette B, Filaire M, et al: Origin and initial 50. Thadhani RI, Carnargo CA, Xavier FJ, et al: Atheroembolic renal
course of the renal arteries: A radiological study. Surg Radiol Anat failure after invasive procedures: Natural history based on 52
23:51-55, 2001. histologically proven cases. Medicine 74:350-358, 1995.
28. Kaufman SL, Chang R, Kadir S, et al: Intraarterial digital subtraction 51. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al; Cholesterol Embolism
angiography in diagnostic arteriography. Radiology 151:323-327, 1984. Study (CHEST) Investigators: The incidence and risk factors of cho-
29. Working Group on Renovascular Hypertension: Detection, evalua- lesterol embolization syndrome, a complication of cardiac catheteriza-
tion, and treatment of renovascular hypertension: Final report. Arch tion: A prospective study. J Am Coll Cardiol 42:211-216, 2003.
Intern Med 147:820-829, 1987. 52. Ramirez G, O’Neill WM, Lambert R, Bloomer HA: Cholesterol
30. Caridi JG, Devane AM, Hawkins IF Jr, Newman R: Examination of embolization: A complication of angiography. Arch Intern Med
renal donors as outpatients using intraarterial digital subtraction 138:1430-1432, 1978.
1786 Section XIX THE MANAGEMENT OF RENOVASCULAR DISORDERS
53. Hou SH, Bushinsky DA, Wish JB, et al: Hospital-acquired renal 75. Bakris GL, Lass NA, Glock D: Renal hemodynamics in radiocontrast
insufﬁciency: A prospective study. Am J Med 74:243-248, 1983. medium-induced renal dysfunction: A role for dopamine-1 receptors.
54. Shusterman N, Strom BL, Murray TG, et al: Risk factors and outcome Kidney Int 56:206-210, 1999.
of hospital-acquired acute renal failure: Clinical epidemiologic study. 76. Hunter DW, Chamsuddin A, Bjarnason H, Kowalik K: Preventing
Am J Med 83:65-71, 1987. contrast-induced nephropathy with fenoldopam. Tech Vasc Interv
55. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC: Risks for renal Radiol 4:53-56, 2001.
dysfunction with cardiac angiography. Ann Intern Med 104:501-504, 77. Tumlin JA, Wang A, Murray PT, Mathur VS: Fenoldopam mesylate
1986. blocks reductions in renal plasma ﬂow after radiocontrast dye
56. Manske CL, Sprafka JM, Strony JT, Want Y: Contrast nephropathy in infusion: A pilot trial in the prevention of contrast nephropathy. Am
azotemic diabetic patients undergoing coronary angiography. Am J Heart J 143:894-903, 2002.
Med 89:615-620, 1990. 78. Stone GW, McCullough PA, Tumlin JA, et al: Fenoldopam mesylate
57. Cigarroa RG, Lange RA, Williams RH, Hillis LD: Dosing of contrast for the prevention of contrast-induced nephropathy: A randomized
material to prevent contrast nephropathy in patients with renal controlled trial. JAMA 290: 2284-2291, 2003.
disease. Am J Med 86(6 Pt 1):649-652, 1989. 79. Paul RE, Durant TM, Oppenheimer MJ, Stauffer HM: Intravenous
58. Gomes AS, Baker JD, Martin-Paredero V, et al: Acute renal dysfunc- carbon dioxide for intracardiac gas contrast in the roentgen diagnosis
tion after major arteriography. AJR Am J Roentgenol 145:1249-1253, of pericardial effusion and thickening. AJR Am J Roentgenol
1985. 78:223-224, 1957.
59. Martin-Paredero V, Dixon SM, Baker JD, et al: Risk of renal failure 80. Oppenheimer MJ, Durant DM, Stauffer H, et al: Cardiovascular-
after major angiography. Arch Surg 118:1417-1420, 1983. respiratory effects and associated changes in blood chemistry. Am J
60. Barrett BJ, Carlisle EJ: Meta-analysis of the relative nephrotoxicity of Physiol 186:325-334, 1956.
high- and low-osmolality iodinated contrast media. Radiology 81. Moore RM, Braselton CW: Injections of air and carbon dioxide into
188:171-178, 1993. a pulmonary vein. Ann Surg 112:212-218, 1940.
61. Jakobsen JA: Renal effects of iodixanol in healthy volunteers and 82. Hawkins IF Jr, Wilcox CS, Kerns SR, Sabatelli FW: CO2 digital
patients with severe renal failure. Acta Radiol 36(Suppl 399):191- angiography: A safer contrast agent for renal vascular imaging? Am J
195, 1995. Kidney Dis 24:685-694, 1994.
62. Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Nephrotoxic risks of 83. Coffey R, Quisling RG, Mickle JP, et al: The cerebrovascular effects
renal angiography: Contrast media-associated nephrotoxicity and of intra-arterial CO2 in quantities required for diagnostic imaging.
atheroembolism—a critical review. Am J Kidney Dis 24:713-727, Radiology 151:405-410, 1984.
1994. 84. Hawkins IF, Caridi JG, Kerns SR: Plastic bag delivery system for
63. Tepel M, van der Giet M, Schwarzfeld C, et al: Prevention of hand injection of carbon dioxide. AJR Am J Roentgenol 165:1-3,
radiographic-contrast-agent-induced reductions in renal function by 1995.
acetylcysteine. N Engl J Med 343:180-184, 2000. 85. Seeger JM, Self S, Harward TR, et al: Carbon dioxide gas as an
64. Kay J, Chow WH, Chan TM, et al: Acetylcysteine for prevention of arterial contrast agent. Ann Surg 217:688-698, 1993.
acute deterioration of renal function following elective coronary 86. Harward TR, Smith S, Hawkins IF, Seeger JM: Follow-up evaluation
angiography and intervention: A randomized controlled trial. JAMA after renal artery bypass surgery with use of carbon dioxide
289:553-558, 2003. arteriography and color-ﬂow duplex scanning. J Vasc Surg 18:23-30,
65. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW: Acetylcysteine to 1993.
prevent angiography-related renal tissue injury (the APART trial). 87. Schreier DZ, Weaver FA, Frankhouse J, et al: A prospective study of
Am J Cardiol 89:356-358, 2002. carbon dioxide-digital subtraction vs standard contrast arteriography
66. Shyu KG, Cheng JJ, Kuan P: Acetylcysteine protects against acute in the evaluation of the renal arteries. Arch Surg 131:503-508, 1996.
renal damage in patients with abnormal renal function undergoing a 88. Kerns SR, Hawkins IF Jr: Carbon dioxide digital subtraction
coronary procedure. J Am Coll Cardiol 40:1383-1388, 2002. angiography: Expanding applications and technical evolution. AJR
67. MacNeill BD, Harding SA, Bazari H, et al: Prophylaxis of contrast- Am J Roentgenol 164:735-741, 1995.
induced nephropathy in patients undergoing coronary angiography. 89. Weaver FA, Pentecost MJ, Yellin AE, et al: Clinical applications of
Catheter Cardiovasc Interv 60:458-461, 2003. carbon dioxide/digital subtraction arteriography. J Vasc Surg 13:266-
68. Efrati S, Dishy V, Averbukh M, et al: The effect of N-acetylcysteine 273, 1991.
on renal function, nitric oxide, and oxidative stress after angiography. 90. Hawkins IF, Caridi JG: Carbon dioxide (CO2) digital subtraction
Kidney Int 64:2182-2187, 2003. angiography: 26-year experience at the University of Florida. Eur
69. Durham JD, Caputo C, Dokko J, et al: A randomized controlled trial Radiol 8:391-402, 1998.
of N-acetylcysteine to prevent contrast nephropathy in cardiac angi- 91. Miller FJ, Mineau DE, Koehler PR, et al: Clinical intra-arterial digital
ography. Kidney Int 62:2202-2207, 2002. subtraction imaging: Use of small volumes of iodinated contrast
70. Briguori C, Manganelli F, Scarpato P, et al: Acetylcysteine and contrast material or carbon dioxide. Radiology 148:273-278, 1983.
agent-associated nephrotoxicity. J Am Coll Cardiol 40:298-303, 2002. 92. Kriss VM, Cottrill CM, Gurley JC: Carbon dioxide (CO2) angi-
71. Boccalandro F, Amhad M, Smalling RW, Sdringola S: Oral ography in children. Pediatr Radiol 27:807-810, 1997.
acetylcysteine does not protect renal function from moderate to high 93. Hawkins IF: Carbon dioxide digital subtraction arteriography. AJR
doses of intravenous radiographic contrast. Catheter Cardiovasc Am J Roentgenol 139:19-24, 1982.
Interv 58:336-341, 2003. 94. Spinosa DJ, Matsumoto AH, Angle JF, et al: Safety of CO(2)- and
72. Allaqaband S, Tumuluri R, Malik AM, et al: Prospective randomized gadodiamide-enhanced angiography for the evaluation and percu-
study of N-acetylcysteine, fenoldopam, and saline for prevention of taneous treatment of renal artery stenosis in patients with chronic
radiocontrast-induced nephropathy. Catheter Cardiovasc Interv renal insufﬁciency. AJR Am J Roentgenol 176:1305-1311, 2001.
57:279-283, 2002. 95. Dowling K, Kan H, Siskin G, et al: Safety of limited supplemental
73. Stevens MA, McCullough PA, Tobin KJ, et al: A prospective iodinated contrast administration in azotemic patients undergoing
randomized trial of prevention measures in patients at high risk for CO2 angiography. J Endovasc Ther 10:312-316, 2003.
contrast nephropathy: Results of the PRINCE study. J Am Coll 96. Beese RC, Bees NR, Belli AM: Renal angiography using carbon
Cardiol 33:403-411, 1999. dioxide. Br J Radiol 73:3-6, 2000.
74. Wiesberg LS, Kurnik PB, Kurnik BRC: Risk of radiocontrast 97. Harward TR, Smith S, Hawkins IF, Seeger JM: Follow-up evaluation
nephropathy in patients with and without diabetes mellitus. Kidney after renal artery bypass surgery with use of carbon dioxide arteri-
Int 45:259-265, 1994. ography and color-ﬂow duplex scanning. J Vasc Surg 18:23-30, 1993.
C H A P T E R 128 Renal Artery Imaging and Physiologic Testing 1787
98. Prince MR, Arnoldus C, Frisoli JK: Nephrotoxicity of high-dose 122. Robertson R, Murphy A, Dubbins PA: Renal artery stenosis: The use
gadolinium compared with iodinated contrast. J Magn Reson Imaging of duplex ultrasound as a screening technique. Br J Radiol 61:196-
6:162-166, 1996. 201, 1988.
99. Niendorf HP, Haustein J, Cornelius I, et al: Safety of gadolinium-DTPA: 123. Mollo M, Pelet V, Mouawad J, et al: Evaluation of colour duplex
Extended clinical experience. Magn Reson Med 22:222-232, 1991. ultrasound scanning in diagnosis of renal artery stenosis, compared to
100. Haustein J, Niendorf HP, Krestin G, et al: Renal tolerance of angiography: A prospective study on 53 patients. Eur J Vasc Endovasc
gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Surg 14:305-309, 1997.
Invest Radiol 27:153-156, 1992. 124. Berland LL, Koslin DB, Routh WD, Keller FS: Renal artery stenosis:
101. Ailawadi G, Stanley JC, Williams DM, et al: Gadolinium as a prospective evaluation of diagnosis with color duplex US compared
nonnephrotoxic contrast agent for catheter-based arteriographic with angiography. Radiology 174:421-423, 1990.
evaluation of renal arteries in patients with azotemia. J Vasc Surg 125. Cochran ST, Krasny RM, Danovitch GM, et al: Helical CT
37:346-352, 2003. angiography for examination of living renal donors. AJR Am J
102. Neindorf HP, Seifert W: Serum iron and serum bilirubin after Roentgenol 168:1569-1573, 1997.
administration of gad-DTPA dimeglumine: A pharmacologic study in 126. Radermacher J, Chavan A, Schaffer J, et al: Detection of signiﬁcant
healthy volunteers. Invest Radiol 23:S275-S280, 1988. renal artery stenosis with color Doppler sonography: Combining
103. Prince MR, Arnoldus C, Frisoli JK: Nephrotoxicity of high dose extrarenal and intrarenal approaches to minimize technical failure.
gadolinium compared with iodinated contrast material. J Magn Reson Clin Nephrol 53:333-343, 2000.
Imaging 6:162-166, 1996. 127. Platt JF: Doppler ultrasound of the kidney. Semin Ultrasound CT
104. Arsenault TM, King BF, Marsh JW Jr, et al: Systemic gadolinium MRI 18:22-32, 1997.
toxicity in patients with renal insufﬁciency and renal failure: 128. Stavros AT, Parker SH, Yakes WF, et al: Segmental stenosis of
Retrospective analysis of initial experience. Mayo Clin Proc 71:1150- the renal artery: Pattern recognition of tardus and parvus abnor-
1154, 1996. malities with duplex sonography. Genitourin Radiol 184:487-492,
105. Haustein J, Niendorf HP, Krestin G, et al: Renal tolerance of 1992.
gadolinium-DTPA/dimeglumine in patients with chronic renal failure. 129. Nazzal MMS, Hoballah JJ, Miller EV, et al: Renal hilar Doppler
Invest Radiol 27:153-156, 1992. analysis is of value in the management of patients with renovascular
106. Burns PN: The physical principles of Doppler and spectral analysis. disease. Am J Surg 174:164-168, 1997.
J Clin Ultrasound 15:567-590, 1987. 130. Halpern EJ, Needleman L, Nack TL, East SA: Renal artery stenosis:
107. Olin JW: Role of duplex ultrasonography in screening for signiﬁcant Should we study the main renal artery or segmental vessels?
renal artery disease. Urol Clin North Am 21:215-226, 1994. Radiology 195:799-804, 1995.
108. Schwerk WB, Restrepo IK, Stellwaag M, et al: Renal artery stenosis: 131. Radermacher J, Chavan A, Bleck J, et al: Use of Doppler ultra-
Grading with image-directed Doppler US evaluation of renal resistive sonography to predict the outcome of therapy for renal-artery stenosis.
index. Radiology 190:785-790, 1994. N Engl J Med 344:410-417, 2001.
109. Postma CT, van Aalen J, De Boo T, et al: Doppler ultrasound scanning 132. Hall NJ, Thorpe RJ, MacKechnie SG: Stenosis of the accessory
in the detection of renal artery stenosis in hypertensive patients. renal artery: Doppler ultrasound ﬁndings. Australas Radiol 39:73-77,
Br J Radiol 65:857-860, 1992. 1995.
110. Bardilli M, Jensen G, Volkmann R, Aurell M: Non-invasive ultra- 133. Oliva VL, Soulez G, Lesage D, et al: Detection of renal artery stenosis
sound assessment of renal artery stenosis by means of the Gosling with Doppler sonography after administration of captopril: Value of
pulsatility index. J Hypertens 10:985-999, 1992. early systolic rise. AJR Am J Roentgenol 171:169-175, 1998.
111. Kohler TR, Zierler RE, Martin RL, et al: Noninvasive diagnosis of 134. Rene PC, Oliva VL, Bui BT, et al: Renal artery stenosis: Evaluation
renal artery stenosis by ultrasonic duplex scanning. J Vasc Surg of captopril. Radiology 196:675-679, 1995.
4:450-456, 1988. 135. Missouris CG, Allen CM, Balen FG, et al: Noninvasive screening
112. Olin JW: Atherosclerotic renal artery disease. Cardiol Clin 20:547- for renal artery stenosis with ultrasound contrast enhancement.
562, 2002. J Hypertens 14:519-524, 1996.
113. Hansen KJ, Tribble RW, Reavis SW, et al: Renal duplex sonography: 136. Claudon M, Plouin PF, Baxter GM, et al: Renal arteries in patients at
Evaluation of clinical utility. J Vasc Surg 12:227-236, 1990. risk of renal arterial stenosis: Multicenter evaluation of the echo-
114. Olin JW, Piedmonte MA, Young JR, et al: The utility of duplex enhancer SH U 508A at color and spectral Doppler US. Levovist
ultrasound scanning of the renal arteries for diagnosing signiﬁcant Renal Artery Stenosis Study Group. Radiology 21:739-746, 2000.
renal artery stenosis. Ann Intern Med 122:833-838, 1995. 137. Strandness DE: Natural history of renal artery stenosis. Am J Kidney
115. Taylor DC, Kettler MD, Moneta G, et al: Duplex ultrasound scanning Dis 24:630-635, 1994.
in the diagnosis of renal artery stenosis: A prospective evaluation. 138. Guzman RP, Zierler RE, Isaacson JA, et al: Renal atrophy and arterial
J Vasc Surg 7:363-369, 1988. stenosis. Hypertension 23:346-350, 1994.
116. Hoffmann U, Edwards JM, Carter S, et al: Role of duplex scanning 139. Taylor DC, Moneta GL, Strandness DE: Follow-up of renal artery
for the detection of atherosclerotic renal artery disease. Kidney Int stenosis by duplex ultrasound. J Vasc Surg 9:410-415, 1989.
39:1232-1239, 1991. 140. Eidt JF, Fry RE, Clagett GP, et al: Postoperative follow-up of renal
117. Simoni C, Balestra G, Bandini A, Rusticali F: [Doppler ultrasound in artery reconstruction with duplex ultrasound. J Vasc Surg 8:667-673,
the diagnosis of renal artery stenosis in hypertensive patients: A 1988.
prospective study]. G Ital Cardiol 21:249-255, 1991. 141. Lantz EJ, Charboneau JW, Hallett JW, et al: Intraoperative color-
118. Handa N, Fukunaga R, Etani H, et al: Efﬁcacy of echo-Doppler Doppler sonography during renal artery revascularization. AJR Am J
examination for the evaluation of renovascular disease. Ultrasound Roentgenol 162:847-852, 1994.
Med Biol 14:1-5, 1988. 142. Duda SH, Erley CM, Wakat JP, et al: Posttransplant renal artery
119. Nchimi A: Duplex ultrasound as ﬁrst-line screening test for patients stenosis—outpatient intra-arterial DSA versus color aided duplex
suspected of renal artery stenosis: Prospective evaluation in high-risk Doppler sonography. Eur J Radiol 16:95-101, 1993.
group. Eur Radiol 13:1413-1419, 2003. 143. Sagalowsky A, McQuitty DM: The assessment and management of
120. Desberg AL, Paushter DM, Lammert GK, et al: Renal artery stenosis: renal vascular hypertension after kidney transplantation. Semin Urol
Evaluation with color Doppler ﬂow imaging. Radiology 177:749-753, 12:221-223, 1994.
1990. 144. Snider JF, Hunter DW, Moradian GP, et al: Transplant renal artery
121. Lewis BD, James EM: Current applications of duplex and color Doppler stenosis: Evaluation with duplex sonography. Radiology 172:1027-
ultrasound imaging: Abdomen. Mayo Clin Proc 643:1158-1169, 1984. 1030, 1989.
1788 Section XIX THE MANAGEMENT OF RENOVASCULAR DISORDERS
145. Blum U, Drumme B, Flugel P, et al: Treatment of ostial renal artery 168. Loubeyre P, Cahen R, Grozel F, et al: Transplant renal artery stenosis:
stenosis with vascular endoprostheses after unsuccessful balloon Evaluation of diagnosis with magnetic resonance angiography com-
angioplasty. N Engl J Med 336:459-465, 1997. pared with color duplex sonography and arteriography. Transplantation
146. Guzman RP, Zierler RE, Isaacson JA, et al: Renal atrophy and arterial 62:446-450, 1996.
stenosis: A prospective study with duplex ultrasound. Hypertension 169. Bennett HF, Li D: MR imaging of renal function. Magn Reson
23:346-350, 1994. Imaging Clin N Am 5:107-126, 1997.
147. Harward TRS, Smith S, Seeger JM: Detection of celiac axis and 170. Taylor J, Summers PE, Keevil SF, et al: Magnetic resonance
superior mesenteric artery occlusive disease with use of abdominal renography: Optimization of pulse sequence parameters and Gd-
duplex scanning. J Vasc Surg 17:738-745, 1993. DPTA dose, comparison with radionuclide renography. Magn Reson
148. Gedroyc WM: Magnetic resonance angiography of renal arteries. Imaging 15:637-649, 1997.
Urol Clin North Am 21:201-214, 1994. 171. Grenier N, Trillaud H, Combe C, et al: Diagnosis of renovascular
149. Grist TM: Magnetic resonance angiography of renal artery stenosis. hypertension: Feasibility of captopril-sensitized dynamic MR imaging
Am J Kidney Dis 24:700-712, 1994. and comparison with captopril scintigraphy. AJR Am J Roentgenol
150. Borrello JA: Renal MR angiography. Genitourin Imaging 5:83-93, 16:835-843, 1996.
1997. 172. Ros PR, Gauger J, Stoupis C, et al: Diagnosis of renal artery stenosis:
151. Müller MF, Prasad PV, Bimmler D, et al: Functional imaging of the Feasibility of combining MR angiography, MR renography, and
kidney by means of the apparent diffusion coefﬁcient. Radiology gadopentetate based measurements of glomerular ﬁltration rate. AJR
193:711-715, 1994. Am J Roentgenol 165:1447-1451, 1995.
152. Roberts DA, Detre JA, Bolinger L, et al: Renal perfusion in humans: 173. Cortsen M, Peterson LJ, Stahlberg F, et al: MR velocity mapping
MR imaging with spin tagging of arterial water. Radiology 196:281- measurement of renal artery blood ﬂow in patients with impaired
286, 1995. kidney function. Acta Radiol 37:79-84, 1996.
153. Prasad PV, Kim D, Kaiser AM, et al: Noninvasive comprehensive 174. Lundin B, Cooper TG, Meyer RA, Potchen J: Measurement of total
characterization of renal artery stenosis by combination of STAR and unilateral renal blood ﬂow by oblique angle velocity encoded 2D-
angiography and EPISTAR perfusion imaging. Magn Reson Med cine magnetic resonance angiography. Magn Reson Imaging 11:51-
38:776-787, 1997. 59, 1993.
154. Niendorf ER, Grist TM, Lee FT, et al: Rapid in vivo measurement of 175. Powers TA, Lorenz CH, Holburn GE, Price RK: Renal artery stenosis:
single-kidney extraction fraction and glomerular ﬁltration rate with In vivo perfusion MR imaging. Radiology 178:543-548, 1991.
MR imaging. Radiology 206:791-798, 1998. 176. Rubin GD: Spiral (helical) CT of the renal vasculature. Semin
155. Schoenberg SO, Knopp MV, Bock M, et al: Renal artery stenosis: Ultrasound CT MR 17:374-397, 1996.
Grading of hemodynamic changes with MR CINE phase-contrast 177. Brink JA, Lim JT, Wang G, et al: Technical optimization of spiral CT
ﬂow measurements. Radiology 203:45-53, 1997. for depiction of renal artery stenosis: In vitro analysis. Radiology
156. DeCobelli F, Vanzuli A, Sironi S, et al: Renal artery stenosis: Evalua- 194:157-163, 1995.
tion with breath-hold, three-dimensional, dynamic, gadolinium- 178. Rubin GD, Dake MD, Napel S, et al: Spiral CT of renal artery
enhanced versus three-dimensional, phase-contrast MR angiography. stenosis: Comparison of three-dimensional rendering techniques.
Radiology 205:689-695, 1997. Radiology 190:181-189, 1994.
157. Leung DA, Nany TF, Debatin JF: Three-dimensional contrast 179. Rubin GD, Dake MD, Napel SA, et al: Three-dimensional spiral CT
enhanced magnetic resonance angiography of the abdominal arterial angiography of the abdomen: Initial clinical experience. Radiology
system. Cardiovasc Intervent Radiol 21:1-10, 1998. 186:147-152, 1993.
158. Prince MR, Narasimhan DL, Stanley JC, et al: Breath-hold 180. Galanski M, Prokop M, Schaefer C, et al: Renal artery stenosis: Spiral
gadolinium-enhanced MR angiography of the abdominal aorta and its CT angiography. Radiology 189:185-192, 1993.
branches. Radiology 197:785-792, 1995. 181. Kaatee R, Beek FJ, de Lange EE, et al: Renal artery stenosis: Detec-
159. Steffens JC, Link J, Crassner J, et al: Contrast enhanced centered tion and quantiﬁcation with spiral CT angiography versus optimized
breath-hold MR angiography of the renal arteries and the abdominal digital subtraction angiography. Radiology 205:121-127, 1997.
aorta. J Magn Reson Imaging 7:617-622, 1997. 182. Farres MT, Lammer J, Schima W, et al: Spiral computed tomographic
160. Hany TF, Debatin JF, Leung DA, Pfammatter T: Evaluation of the angiography of the renal arteries: A prospective comparison with
aortoiliac and renal arteries: Comparison of breath-hold contrast- intravenous and intra-arterial digital subtraction angiography.
enhanced three-dimensional MR angiography with conventional Cardiovasc Intervent Radiol 19:101-106, 1996.
catheter angiography. Radiology 204:357-362, 1997. 183. Cikrit DF, Harris JV, Hemmer DG, et al: Comparison of spiral CT
161. Rieumont MJ, Kaufman JA, Geller SC, et al: Evaluation of renal scan and arteriography for evaluation of renal and visceral arteries.
artery stenosis with dynamic gadolinium enhanced MR angiography. Ann Vasc Surg 10:109-116, 1996.
AJR Am J Roentgenol 169:39-44, 1997. 184. Wittenberg G, Kenn W, Tschammler A, et al: Spiral CT angiography
162. Holland GA, Dougherty L, Carpenter JP, et al: Breath-hold ultrafast of renal arteries: Comparison with angiography. Eur Radiol 9:546-
three-dimensional gadolinium-enhanced MR angiography of the 551,1999.
aorta and the renal and other visceral abdominal arteries. AJR Am J 185. Deregi JP, Elkohen M, Deklunder G, et al: Helical CT angiography
Roentgenol 166:971-981, 1996. compared with arteriography in the detection of renal artery stenosis.
163. Hany TF, Leung DA, Pfammatter T, Debatin JF: Contrast-enhanced AJR Am J Roentgenol 167:495-501, 1996.
magnetic resonance angiography of the renal arteries. Invest Radiol 186. Kim TS, Chung JW, Park JH, et al: Renal artery evaluation:
33:653-665, 1998. Comparison of spiral CT angiography to intra-arterial DSA. J Vasc
164. Schoenberg SO, Knopp MV, Londy F, et al: Morphologic and Interv Radiol 9:553-559, 1998.
functional magnetic resonance imaging of renal artery stenosis: A 187. Lerman LO, Taler SJ, Textor SC, et al: Computed tomography derived
multireader tricenter study. J Am Soc Nephrol 13:158-169, 2002. intrarenal blood ﬂow in renovascular and essential hypertension.
165. Prince MR: A gadolinium enhanced MR aortography. Radiology Kidney Int 49:846-854, 1996.
191:155-164, 1994. 188. Gomes MN, Davros WJ, Zeman RK: Preoperative assessment of
166. Gedroyc WM, Negus R, Al-Kutoubi A, et al: Magnetic resonance abdominal aortic aneurysm: The value of helical and three-
angiography of renal transplants. Lancet 339:789-791, 1992. dimensional computed tomography. J Vasc Surg 20:367-375, 1994.
167. Johnson DB, Lerner CA, Prince MR, et al: Gadolinium-enhanced 189. Todd GJ, Nowygrod R, Benvenisty A, et al: The accuracy of CT
magnetic resonance angiography of renal transplants. Magn Reson scanning in the diagnosis of abdominal and thoracoabdominal aortic
Imaging 15:13-20, 1997. aneurysms. J Vasc Surg 13:302-310, 1991.